Systemic corticosteroids in coronavirus disease 2019 (COVID-19)-related smell dysfunction: an international view.

Huart, Caroline; Philpott, Carl M; Altundag, Aytug; Fjaeldstad, Alexander W; Frasnelli, Johannes; Gane, Simon; Hsieh, Julien W; Holbrook, Eric H; Konstantinidis, Iordanis; Landis, Basile N; Macchi, Alberto; Mueller, Christian A; Negoias, Simona; Pinto, Jayant M; Poletti, Sophia C; Ramakrishnan, Vijay R; Rombaux, Philippe; Vodicka, Jan; Welge-Lüessen, Antje; Whitcroft, Katherine L; ... (2021). Systemic corticosteroids in coronavirus disease 2019 (COVID-19)-related smell dysfunction: an international view. International forum of allergy & rhinology, 11(7), pp. 1041-1046. Wiley 10.1002/alr.22788

Full text not available from this repository. (Request a copy)

The frequent association between coronavirus disease 2019 (COVID-19) and olfactory dysfunction is creating an unprecedented demand for a treatment of the olfactory loss. Systemic corticosteroids have been considered as a therapeutic option. However, based on current literature, we call for caution using these treatments in early COVID-19-related olfactory dysfunction because: (1) evidence supporting their usefulness is weak; (2) the rate of spontaneous recovery of COVID-19-related olfactory dysfunction is high; and (3) corticosteroids have well-known potential adverse effects. We encourage randomized placebo-controlled trials investigating the efficacy of systemic steroids in this indication and strongly emphasize to initially consider smell training, which is supported by a robust evidence base and has no known side effects.

Item Type:

Journal Article (Review Article)

Division/Institute:

04 Faculty of Medicine > Department of Head Organs and Neurology (DKNS) > Clinic of Ear, Nose and Throat Disorders (ENT)

UniBE Contributor:

Poletti, Sophia

Subjects:

600 Technology > 610 Medicine & health

ISSN:

2042-6984

Publisher:

Wiley

Language:

English

Submitter:

Stefan Weder

Date Deposited:

25 Jan 2022 11:41

Last Modified:

05 Dec 2022 16:00

Publisher DOI:

10.1002/alr.22788

PubMed ID:

33728824

Uncontrolled Keywords:

COVID-19 SARS-CoV-2 corticosteroids olfaction disorder smell

URI:

https://boris.unibe.ch/id/eprint/163547

Actions (login required)

Edit item Edit item
Provide Feedback